Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time?
Author(s) -
Thomas A. Hope,
Marianne Pavel,
Emily K. Bergsland
Publication year - 2022
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.22.00176
Subject(s) - radionuclide therapy , medicine , neuroendocrine tumors , peptide receptor , dosing , biomarker , oncology , somatostatin receptor , somatostatin , receptor , biochemistry , chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom